Octreotide Acetate Injection 50 mcg/mL, 1 mL single-dose vial, Rx only, Teva Pharmaceuticals USA. Inc. North Wales, PA 19454, NDC 0703-3301-01
Recall Number: D-0745-2021
Firm: Teva Pharmaceuticals USA
Classification: Class II
Status: Terminated
Report Date: 20210825
Initiation Date: 20210729
Termination Date: 20240604
Reason for Recall
Lack of Assurance of Sterility
Product Description
Octreotide Acetate Injection 50 mcg/mL, 1 mL single-dose vial, Rx only, Teva Pharmaceuticals USA. Inc. North Wales, PA 19454, NDC 0703-3301-01